Background illustration for clinical trials search

Paid Clinical Trials Arlington

Discover 1,944 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

for
Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy,
Location: Dallas TX, Houston TX, Nashville TN, Aurora CO,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07223203

Phase 3, Recruiting

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

for
Lung Neoplasm
Location: Dallas TX, Lexington KY, Fairfax VA, Baltimore MD
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06780098

Phase 2, Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

for
Somatostatin Receptor Positive (SSTR+),
Location: Dallas TX, Fayetteville AR, New Orleans LA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06784752

Phase 3, Recruiting

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Dallas TX, Houston TX, Denver CO, Nashville TN,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06108050

Phase 1, Recruiting

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

for
Breast Cancer
Location: Dallas TX, San Antonio TX, Nashville TN, Salem VA,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 18+

Code: NCT05748834

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

for
Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis,
Location: Southlake TX, Garland TX, Cedar Park TX, San Antonio TX,
Sponsor: Spyre Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012395

Phase 2, Recruiting

IEEM- Work:Rest Cycles in Burn Survivors- Humidity

for
Hyperthermia, Burn Injury
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 65

Code: NCT06966336

Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer (NSCLC)
Location: Dallas TX, Lincoln NE, Nashville TN, Atlanta GA,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07288177

Phase 2, Recruiting

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

for
Moderate Aortic Valve Stenosis
Location: Plano TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: Kardigan, Inc.

Sex: All

Age: 50+

Code: NCT07001800

Phase 2, Phase 3, Recruiting

KRT-232 and TKI Study in Chronic Myeloid Leukemia

for
Chronic Myeloid Leukemia
Location: Dallas TX, Birmingham AL, Milwaukee WI, Augusta GA,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04835584

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

for
Recurrent or Metastatic Solid Tumors
Location: Dallas TX, Pearland TX, Amarillo TX, Germantown TN,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06330064

Phase 1, Phase 2, Recruiting

Tesetaxel as First-line Therapy for Metastatic Breast Cancer

for
Breast Neoplasm
Location: Dallas TX, Greensboro NC, New York NY
Sponsor: Genta Incorporated

Sex: Female

Age: 18+

Code: NCT01221870

Phase 2, Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

for
Hepatitis B Virus Infection
Location: Webster TX, San Antonio TX, Lenexa KS, Iowa City IA,
Sponsor: GigaGen, Inc.

Sex: All

Age: 18+

Code: NCT07024641

Phase 1, Recruiting

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Dallas TX, Tyler TX, Austin TX, Houston TX,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05650632

Phase 1, Recruiting

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Dallas TX, Springfield MO, Kansas City MO, Columbia MO,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06369285

Phase 2, Recruiting

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

for
Breast Cancer, Breast Neoplasms, Breast Cancers
Location: Dallas TX
Sponsor: Baylor Research Institute

Sex: All

Age: 18+

Code: NCT06517212

Phase 2, Recruiting

Sickle Cell Kidney Biorepository

for
Sickle Cell Trait, Sickle Cell Disease (SCD),
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 65

Code: NCT07064174

Recruiting

Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC

for
Breast Cancer
Location: Dallas TX
Sponsor: Baylor Research Institute

Sex: Female

Age: 18+

Code: NCT04265872

Early Phase 1, Recruiting

Neratinib in Combination With Ruxolitinib in Patients With mTNBC

for
Metastatic Triple-Negative Breast Carcinoma, Breast Cancer
Location: Dallas TX
Sponsor: Baylor Research Institute

Sex: Female

Age: 18+

Code: NCT06008275

Early Phase 1, Recruiting

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

for
Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia
Location: Dallas TX, Laredo TX, Appleton WI, Toledo OH,
Sponsor: NGM Biopharmaceuticals, Inc

Sex: All

Age: 18+

Code: NCT07033026

Phase 2, Recruiting